National Prostate Cancer Audit

🚨The latest National Prostate Cancer Audit Newsletter is OUT, you can read it here www.natcan.org.uk/news/npca-ne...

Packed full of news, information and links! Please share it widely.

@natcan-news.bsky.social @hqip.bsky.social

London Global Cancer Week Webinar: Driving Improvements in Cancer - National Cancer Audit Collaborating Centre NATCAN will join London Global Cancer Week (LGCW) to host a webinar on how data-driven approaches drive improvements in cancer. LGCW is an annual international event dedicated to addressing the…

🎙️NATCAN will be hosting a webinar @londonglobalcancer.bsky.social in four weeks time!

📅 Webinar: 27 Nov | 🕥 10:30–12:00 GMT

Find out more about the agenda, and join us to explore how to drive improvements in cancer care.
🔗 buff.ly/Murx42E

#LondonGlobalCancerWeek #LGCW2025

Sign up for our webinar with @bursturology.bsky.social on Thursday 23 October, 09.00 to hear experts discuss the use of systemic anti-cancer treatment in metastatic prostate cancer and submit questions in advance 👇

www.natcan.org.uk/events/webin...

See you there! @alison-tree.bsky.social

📢 The NPCA State of the Nation Report 2025 is OUT!

Find the report, supplementary documents & provider results here www.natcan.org.uk/reports/npca...

@natcan-news.bsky.social @hqip.bsky.social @prostatecanceruk.bsky.social @alison-tree.bsky.social @nhsengland.bsky.social

Please share!

💡NPCA Clinical Lead @alison-tree.bsky.social will present (unpublished) key findings from the upcoming State of the Nation Report and NPCA research updates at the British Uro-oncology Group Annual Meeting.
🗓️ Sept 13 @ 9.15
🔗 buff.ly/indAGME

@hqip.bsky.social @natcan-news.bsky.social

Article: The value of audit in identifying health inequalities – HQIP The National Prostate Cancer Audit (NPCA) explains how clinical audit highlights unwarranted differences in diagnoses and treatment, as part of Clinical Audit Awareness Week.

ICYMI Read the National Prostate Cancer Audit blog post for Clinical Audit Awareness Week #CAAW25 @hqip.bsky.social

"The value of audit in identifying health inequalities"

www.hqip.org.uk/article-natc...

Draws on NPCA State of the Nation report from January 2025 www.npca.org.uk/reports/npca...

⚠️ ICYMI our latest study investigating

👉 geographic
👉 socioeconomic
👉 demographic

inequalities in the incidence of metastatic prostate cancer at time of diagnosis in England

bmjoncology.bmj.com/content/bmjo...

Taken together, these findings highlight the importance of refocusing efforts on prostate cancer screening and detection policies in England and the UK.

@natcan-news.bsky.social @alison-tree.bsky.social @prostatecanceruk.bsky.social

A higher rate of metastatic prostate cancer and a lower rate of prostate cancer overall was also seen among men living in more deprived neighbourhoods, suggesting that the risk of being diagnosed with metastatic prostate cancer is also linked to their socioeconomic background.

⚠️ Another key finding of this study is that higher rates of metastatic prostate cancer were seen in regions with lower rates of prostate cancer diagnosis overall which may be linked to variation in the use of PSA testing.

🚨 Regional annual rates were found to vary between 4 and 7 per 100 000 men, with the highest rates seen in Northern England; South Yorkshire and Bassetlaw; Humber, Coast and Vale; West Yorkshire and Harrogate; and the Peninsula. The lowest rates were seen in London and the South-East.

Geographic, socioeconomic and demographic inequalities in the incidence of metastatic prostate cancer at time of diagnosis in England: a population-based evaluation Objective To evaluate the area-based incidence of metastatic prostate cancer at diagnosis, reflecting the risk of late-stage diagnosis, and overall prostate cancer incidence, reflecting the risk of ov...

📢 Start your week with the latest National Prostate Cancer Audit study.

We found that the annual rate of metastatic prostate cancer at diagnosis was more than 60% higher in some regions than in others in England.

Paper link here 👉 bmjoncology.bmj.com/content/4/1/...

The *first* National Prostate Cancer Audit Quarterly Data Dashboard is LIVE 📊

Cohort and indicator details can be found here www.npca.org.uk/reports/npca... and the dashboard is accessible here rcs-ceu.shinyapps.io/NPCA/

Please share these links and tell us what you think! 📝 npca@rcseng.ac.uk

Everything you ever wanted to know about the National Cancer Audit Collaboration Centre (NATCAN @natcan-news.bsky.social), which the prostate audit is part of, is now available in a very handy summary paper form!

Read it here www.sciencedirect.com/science/arti...

Please share it far and wide!

🚨 10 days left to apply for the National Prostate Cancer Audit Clinical Fellow position!

Come and join the team
👉 www.jobs.ac.uk/job/DMB374/c...

#EAU25

ICYMI last week, the NPCA's latest publication

"Are evidence-based guidelines translating into clinical practice? A national population-based study of the use of treatment intensification in metastatic hormone-sensitive prostate cancer (mHSPC) in England"

👉 www.ejcancer.com/action/showP...

👉 Use varied across sMDTs from 20% to 54%, with greater variation in older patients

👉 Findings highlight underuse and the need for standardised care to address disparities

We hope you find this paper useful and please get in touch with any feedback npca@rcseng.ac.uk

Graph showing percentage patients treated on the y axis and patient age on the x axis marking the probability of treatment according to age. A sharp drop in the probability is seen at the age of 75 yrs.

The study explored variation in treatment intensification for mHSPC across England and found

👉 Only 39% received intensification with lower uptake in Black and deprived populations

👉 Intensification was given to 60% of men under 75 but dropped to 17% in those over 75

📢 End your week with our hot off the press paper:

"Are Evidence-Based Guidelines Translating into Clinical Practice? A National Population-Based Study of the Use of Treatment Intensification in Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) in England"

www.ejcancer.com/article/S095...

National Prostate Cancer Audit March 2025 Newsletter summarising content from the State of the Nation Report and linking to the fifth Quarterly Report.

🚨 Our March 2025 Newsletter is out! www.npca.org.uk/news/npca-ma...

Summarising our findings from the State of the Nation Report www.npca.org.uk/reports/npca... and linking to our latest quarterly report www.npca.org.uk/reports/npca...

Read it and share!

More details about the NPCA can be found here buff.ly/4kiLhxy and reports buff.ly/4klANxy and publications buff.ly/4kn1HF1. Enquiries can be made to npca@rcseng.ac.uk. Closing date 31st March 2025.

Please share widely @alison-tree.bsky.social @natcan-news.bsky.social @prostateukprofs.bsky.social

Clinical Fellow for the National Prostate Cancer Audit at The Royal College of Surgeons of England Start your UK & international job search for academic jobs, research jobs, science jobs and managerial jobs in leading universities and top...

If the answer to these questions is yes, look no further! The National Prostate Cancer Audit (NPCA) is recruiting a Clinical Fellow to work with our large and detailed outcome-linked dataset to undertake research for patient benefit. Apply here www.jobs.ac.uk/job/DMB374/c...

Picture saying that the National Prostate Cancer Audit is hiring a Clinical fellow with details on the NPCA email address and website.

Do you want to help strengthen NHS cancer services & reduce variation in prostate cancer care? Are you a clinical oncological or urological trainee looking to pursue an MD or PhD with an expert clinical/audit team at the National Cancer Audit Collaborating Centre (NATCAN) buff.ly/4hW4zHz?

The next quarterly report will be published in April 2025, to align with the reporting schedule for all other NATCAN audits, and will mark the NPCA transition to using an RShiny dashboard. Examples of the NATCAN dashboards for other tumour types can be found here https://buff.ly/4gIQLyu

The National Prostate Cancer Audit's 5th Quarterly Report is OUT! Download it here https://buff.ly/4b30oXB

Please share it widely 📢

All feedback is welcome, either here as a comment or via email npca@rcseng.ac.uk

It also finds inequalities in diagnoses and treatments by age, deprivation and ethnicity. The full report, appendices and data tables are available here https://buff.ly/4hKkSXc . Our patient summary can be found here https://buff.ly/40DTMu2 #WorldCancerDay

The National Prostate Cancer Audit State of the Nation Report's key findings include an increase in the number of men diagnosed with prostate cancer (>55,000 in 2023 in England, now the most common cancer in England) & a concurrent increase in the number of men receiving treatments #WorldCancerDay

The full report and supplemental information is available here www.npca.org.uk/reports/npca....

We also have a patient summary here www.npca.org.uk/reports/npca...

Please share the report far and wide! If you have any questions or feedback on our report, please contact us at npca@rcseng.ac.uk

National Disease Registration Service - NDRS The National Disease Registration Service (NDRS) collects patient data on cancer, congenital anomalies and rare diseases, and provides expert, timely analysis to support clinical teams, academics, cha...

Thank you to our data partners: the National Disease Registration Service (NDRS) digital.nhs.uk/ndrs/ & the Data Access Request Service (DARS) digital.nhs.uk/services/dat... (England) & the Cancer Network Information System Cymru (CaNISC) (Wales)